Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on July 12, 2007. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

A -- BAA07-08 Polymer Ice

Closed
BAA07-08Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

N/A

Place of Performance

VA

Set-Aside

NONE

Documents

2

20070116152842.zip

ZIP

20070116153247.zip

ZIP

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Response Deadline

Deadline has passed

Posted

Solicitation

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Advanced Research Projects Agcy
Contacts1 person available
OfficeARLINGTON, VA, 222032114, USA
Office AddressARLINGTON, VA, 222032114, USA
Contacts
Anthony E. CicalaContracting Officer

Full Description

Show more
Description BROAD AGENCY ANNOUNCEMENT (BAA) 07-08 DARPA Polymer Ice WHITEPAPERS DUE 03/06/2007 FULL PROPOSALS DUE 04/24/2007, TECHNICAL POC: Dr. Mitchell Zakin, DARPA/DSO, Phone: (703) 248-1509, Email: baa07-08-@darpa.mil; URL: www.darpa.mil/dso. PROGRAM OBJECTIVES AND DESCRIPTION: The unrestricted mobility of enemy forces in the crowded urban battle space, including individual combatants and vehicles, severely reduces the effectiveness of military and peacekeeping operations. This, coupled with difficulties in the identification of adversaries amongst the local populace, creates a dangerous, uncertain, high-risk environment that risks coalition and civilian casualties. As such, there is an immediate need for methods to deny enemy transit while simultaneously maintaining our own. An effective solution is found from the basic tenet: to get from Point A to Point B, one must have sufficient traction with the ground. In response to this challenge, the Defense Advanced Research Projects Agency (DARPA) is seeking innovative proposals to develop Polymer Ice, a polymer-based artificial ice material that achieves effective mobility control by the precise and reversible reduction of ground traction. The Polymer Ice program aims to replicate the properties of black ice, a thin, translucent, slippery coating of ice on roadway surfaces that forms spontaneously in cold temperatures, but for use in a broad range of hot, arid environments such as found in Iraq and Afghanistan. A non-toxic reversal agent, carefully matched to the chemical characteristics of Polymer Ice, will be developed to rapidly restore traction when applied to a Polymer Ice-coated surface. Most importantly, incorporation of the reversal agent into combat boots and tires, to achieve instantaneous traction restoration on contact, will provide true asymmetric mobility capabilities to our war fighters. This is akin to having the ability to run effortlessly on wet ice, while adversary mobility is simultaneously severely restricted. It is envisioned that a Mobility Control System would consist of Polymer Ice (or raw materials used to produce Polymer Ice in real-time), a spray-on reversal agent, boots/tires with built-in reversal agent, a dispersal means, and a means for clean-up of the reversed material. Such a system will provide unprecedented situational control and sustained operational tempo, including the ability to shape the terrain by constraining adversaries to specific areas, control ingress/egress to buildings, degrade the ability of our adversaries to shoot and chase us, and gain time for our war fighters to act rather than react. PROPOSAL EVALUATION: Evaluation of proposals will be accomplished through a technical review of each proposal using the following criteria, in descending order of importance: 1. SCIENTIFIC AND TECHNICAL MERIT 2. VALUE TO DEFENSE 3. CAPABILITY OF THE PERSONNEL AND FACILITIES TO PERFORM THE PROPOSED EFFORT 4. COST REALISM AND REASONABLENESS ADDITIONAL GUIDANCE: Proposers choosing to respond to this BAA must read the associated PIP available at www.fedbizopps.gov and www.grants.gov, which provides specific information about this BAA, including instructions on how to respond. Point of Contact Anthony E. Cicala, Contracting Officer, Phone: (571) 218-4639, Fax: (703) 248-1927, Email: anthony.cicala@darpa.mil

More opportunities from Department Of Defense → Defense Advanced Research Projects Agcy

Same awarding agency

NAICS: 541714
New
Federal
Pre-Award Synopsis Texas Shield
Solicitation # DARPA-SN-27-07
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), intends to enter into an agreement with The University of Texas System consortium of universities for the Texas Shield Program. This integrated research initiative, identified by solicitation number DARPA-SN-27-07 and NAICS code 541714, focuses on developing autonomous and semi-autonomous medical technologies and scalable solutions for critical medical consumables. The primary goal is to support lifesaving medical care in contested, austere, and resource-limited environments. Key technical areas of focus include autonomous medical and robotic surgical systems, casualty evacuation, artificial-blood and supply innovation, AI-enabled clinical decision support, and mass-casualty science and simulation. This notice is a pre-award synopsis and is not a request for proposals or a competitive solicitation. Interested entities are invited to submit information by November 15, 2026, to TexasShieldxBTO@darpa.mil detailing their technical expertise, integrated research infrastructure, clinical-validation capabilities, and multi-institutional coordination capacity. Additionally, respondents must describe their consortium organizational structure, commercialization capabilities, facility clearance levels, and their ability to handle Controlled Unclassified Information. The government will not reimburse any costs associated with the preparation or submission of information in response to this notice.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

5 days ago

DEADLINE

in 25 days
View Details
NAICS: 541715
New
Federal
Intrinsic Market Resilience (IMR)
Solicitation # DARPA-PS-26-138
The Intrinsic Market Resilience (IMR) program, solicited by the DARPA Information Processing Techniques Office under DARPA-PS-26-138, is a 32-month initiative spanning Fiscal Years 2027 through 2029. The program aims to protect essential U.S. economic sectors from systemic risks and adversarial attacks targeting the public interfaces of modern electronic markets. By combining Large Language Model (LLM) automation with rigorous mathematical modeling, IMR seeks to develop tools that automatically translate informal regulatory and technical specifications into formal models to identify hidden weaknesses and recommend structural repairs. The work is divided into three technical areas: TA1 focuses on modeling and analysis, TA2 on resiliency and repair, and TA3 on establishing test and evaluation frameworks to validate the outputs of the first two areas. This procurement is conducted as an Other Transaction (OT) for Prototype Agreement under 10 U.S.C. 4022, with anticipated award ranges of 4.5 to 5 million dollars for TA1, 2.5 to 3 million dollars for TA2, and 5 to 6.5 million dollars for TA3. Eligible participants include small businesses, nonprofit research institutions, and nontraditional defense contractors. Proposers must adhere to strict security requirements, including CMMC Level 1 compliance at award and CMMC Level 2 status or a detailed compliance plan. All information must be handled according to NIST 800-171 and DFARS 252.204-7012 standards. Evaluation is based on technical approach, qualifications, technology transition viability, price, and security, with a particular emphasis on innovation and the feasibility of the proposed technical solution.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

5 days ago

DEADLINE

in about 2 months
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS